Clinical trial
A Phase 1 Double-Blind Crossover Comparative Study of Neurofeedback for the Treatment of Parkinson's Disease
NCT03837548 is registered in ClinicalTrials.gov with Osaka University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Double-Blind Crossover Comparative Study of Neurofeedback for the Treatment of Parkinson's Disease
- Lead sponsor
- Osaka University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2019
- Completion date
- March 31, 2022
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.